USPTO serial 90295872
INTELLIMAMMO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 2, 2023
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with INTELLIMAMMO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Halifax, NS, CA
Halifax, NS, CA
Halifax, NS, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey R. Cadwell
Jeffrey R. Cadwell DORSEY & WHITNEY LLP50 SOUTH SIXTH STREETSUITE 1500MINNEAPOLIS, MN 55402-1498Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; downloadable and recorded computer software for medical diagnostic imaging; downloadable and recorded computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, namely, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; downloadable and recorded computer software for processing and analysis of radiological images for medical diagnostic imaging; downloadable and recorded computer software in the field of medical diagnostic imaging for managing quality control including training; downloadable and recorded computer software, for medical diagnostic imaging using algorithms, to facilitate the comparison of metrics, medical and healthcare analytics and informatics, and data capture, and clinical decision tools; computers and tablet computers for medical use, use with x-ray machines, use for medical diagnosis, use for imaging purposes; downloadable and recorded computer software for quality control, namely, computer software for use in controlling quality of diagnostic medical images, and for providing quality assurance in medical screening for diagnostic and treatment purposes in medical screening for diagnostic and treatment purposes | ACTIVE | Nov 12, 2020 |
| 042 | Software research, development, engineering, design, installation, creation for medical diagnostic imaging; software research, development, engineering, design, installation, creation in the fields of medicine, health, disease, pharmacology, oncology, and radiology for medical diagnostic imaging; medical technology development and research in the field of medical diagnostic imaging; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in cancer diagnosis and cancer treatment; platform as a service (PAAS) featuring computer software for medical diagnostic imaging; platform as a service (PAAS) featuring computer software platforms for medical diagnostic imaging, namely, software to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of breast density, and breast cancer; software as service (SAAS) services featuring software for use in the fields of medicine, health and disease, namely, software to facilitate better image quality of medical diagnostic imagery, breast imaging, screening measurement of breast density, and breast cancer; platform as a service (PAAS) featuring computer software for medical diagnostic imaging for use in health information systems for receiving, processing, transmitting, and displaying patient medical data, namely, diagnostic test results, diagnostic medical images, and patient personal data, and controlling and managing patient health information; software design in the field of medical diagnostic imaging; medical software design in the field of medical diagnostic imaging; research services in the fields of medicine, health care, disease, pharmacology, oncology, and radiology | ACTIVE | Nov 12, 2020 |
| 044 | Providing medical information to patients and medical professionals in the form of downloadable medical reports in the field of medical diagnostic imaging for patient care, regulatory compliance, and medical clinic operations, for display on computer screens | ACTIVE | Nov 12, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Densitas Inc.
- Other trademarks owned by Densitas Inc.
- Other trademarks owned by Densitas Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INTELLIMAMMO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 2, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 2, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 30, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 29, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 23, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 22, 2023 | IUAF | USE AMENDMENT FILED | — |
| Mar 22, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 14, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 12, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 12, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 19, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 18, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 16, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 12, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 12, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 12, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 17, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 17, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2021 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 9, 2021 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 28, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2021 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 13, 2021 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Apr 13, 2021 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Apr 13, 2021 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 6, 2020 | NWAP | NEW APPLICATION ENTERED | — |